Effect of Host Plant Resistance to Tomato yellow leaf curl virus (TYLCV) on Virus Acquisition and Transmission by Its Whitefly Vector.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 18943336)

Published in Phytopathology on December 01, 2001

Authors

M Lapidot, M Friedmann, M Pilowsky, R Ben-Joseph, S Cohen

Articles citing this

The virulence-transmission trade-off in vector-borne plant viruses: a review of (non-)existing studies. Philos Trans R Soc Lond B Biol Sci (2010) 1.06

Insect symbiont facilitates vector acquisition, retention, and transmission of plant virus. Sci Rep (2013) 0.92

An invasive whitefly feeding on a virus-infected plant increased its egg production and realized fecundity. PLoS One (2010) 0.91

A Novel Route Controlling Begomovirus Resistance by the Messenger RNA Surveillance Factor Pelota. PLoS Genet (2015) 0.90

Temporal Effects of a Begomovirus Infection and Host Plant Resistance on the Preference and Development of an Insect Vector, Bemisia tabaci, and Implications for Epidemics. PLoS One (2015) 0.79

Quantification and localization of Watermelon chlorotic stunt virus and Tomato yellow leaf curl virus (Geminiviridae) in populations of Bemisia tabaci (Hemiptera, Aleyrodidae) with differential virus transmission characteristics. PLoS One (2014) 0.79

Recessive Resistance Derived from Tomato cv. Tyking-Limits Drastically the Spread of Tomato Yellow Leaf Curl Virus. Viruses (2015) 0.75

The Contrasting Effects of Elevated CO2 on TYLCV Infection of Tomato Genotypes with and without the Resistance Gene, Mi-1.2. Front Plant Sci (2016) 0.75

Elevated O₃ and TYLCV Infection Reduce the Suitability of Tomato as a Host for the Whitefly Bemisia tabaci. Int J Mol Sci (2016) 0.75

Transcriptome analysis of host-associated differentiation in Bemisia tabaci (Hemiptera: Aleyrodidae). Front Physiol (2014) 0.75

Articles by these authors

(truncated to the top 100)

A global measure of perceived stress. J Health Soc Behav (1983) 56.90

Stress, social support, and the buffering hypothesis. Psychol Bull (1985) 19.28

Socioeconomic status and health. The challenge of the gradient. Am Psychol (1994) 13.59

Epidermal growth factor. Annu Rev Biochem (1979) 11.82

125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol (1976) 10.88

Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem (1972) 10.86

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65

Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem (1980) 7.71

Beta Alanine as a Growth Accessory for the Diphtheria Bacillus. J Bacteriol (1937) 7.51

Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci U S A (1978) 5.91

Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol (1979) 5.62

Does hiatus hernia affect competence of the gastroesophageal sphincter? N Engl J Med (1971) 5.44

Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem (1980) 5.19

Epidermal growth factor. J Biol Chem (1990) 4.79

Prophylactic vs therapeutic blood patch for obstetric patients with accidental dural puncture--a randomised controlled trial. Anaesthesia (2014) 4.75

IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS. J Exp Med (1945) 4.69

The primary structure of epidermal growth factor. J Biol Chem (1972) 4.41

Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A (1978) 4.03

The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity (1995) 3.99

Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol (1976) 3.91

IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM. J Exp Med (1945) 3.89

A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem (1982) 3.81

IN VITRO AND IN VIVO EFFECTS OF A NERVE GROWTH-STIMULATING AGENT ISOLATED FROM SNAKE VENOM. Proc Natl Acad Sci U S A (1956) 3.64

THE INFLUENCE OF PROTEIN INTAKE ON THE UREA CLEARANCE IN NORMAL MAN. J Clin Invest (1934) 3.60

Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature (1976) 3.56

Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature (1978) 3.54

Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor. Proc Natl Acad Sci U S A (1979) 3.54

Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature (2000) 3.51

Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem (1975) 3.48

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46

Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science (1993) 3.30

Heterogeneity of the peptide chains of gamma-globulin. Biochem J (1964) 3.25

Action of malarial antibody in vitro. Nature (1969) 3.24

Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem (1979) 3.18

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10

Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun (1982) 3.01

ABC of intensive care. Withdrawal of treatment. BMJ (1999) 2.96

Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A (1975) 2.95

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94

Social support and smoking cessation and maintenance. J Consult Clin Psychol (1986) 2.92

Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol (1979) 2.88

The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med (1973) 2.86

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet (1999) 2.83

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen. Parasite Immunol (1988) 2.79

In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 2.75

Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc (Wash) (1998) 2.74

Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol (1989) 2.72

Properties of protective malarial antibody. Immunology (1970) 2.65

Rapid induction of morphological changes in human carcinoma cells A-431 by epidermal growth factors. J Cell Biol (1979) 2.61

Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56

The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol (1984) 2.54

A simple technique to reduce the incidence of accidental dural puncture. Anaesthesia (2001) 2.53

Stress and immunity in humans: a meta-analytic review. Psychosom Med (1993) 2.52

Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1983) 2.50

The distribution of antigenic and nonantigenic compounds within draining lymph nodes. Lab Invest (1966) 2.49

Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48

Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cells. Biochemistry (1981) 2.46

Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol (1996) 2.46

Nobel laureates' letter to President Bush. Washington Post (2001) 2.43

Inconsistent visual analyses of intrasubject data. J Appl Behav Anal (1979) 2.43

A merozoite vaccine effective against Plasmodium knowlesi malaria. Nature (1974) 2.39

Group support interventions for women with breast cancer: who benefits from what? Health Psychol (2000) 2.38

In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med (1971) 2.36

Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33

Depression and immunity: a meta-analytic review. Psychol Bull (1993) 2.30

Investigation of benefits and costs of an ophthalmic outreach clinic in general practice. Br J Gen Pract (1995) 2.26

Absence of circular plasmid deoxyribonucleic acid attributable to a genetic determinant for methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 2.25

Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25

Our new President: Frank P. Brooks. Gastroenterology (1980) 2.24

Cytoplasmic pH regulation in thymic lymphocytes by an amiloride-sensitive Na+/H+ antiport. J Gen Physiol (1984) 2.23

In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology (1975) 2.23

Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21

Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem (1984) 2.21

Merozoite vaccination against Plasmodium knowlesi malaria. Immunology (1975) 2.21

Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol (2001) 2.16

Plant virus movement proteins. Cell (1992) 2.14

Structure and biological properties of immunoglobulins. Adv Immunol (1967) 2.08

Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin. J Clin Invest (1971) 2.07

Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology (1976) 2.05

Constitutive penicillinase formation in Staphylococcus aureus owing to a mutation unlinked to the penicillinase plasmid. J Bacteriol (1968) 2.03

A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. J Biol Chem (1990) 2.02

First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00

Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol (1982) 1.97

Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet (1977) 1.95

Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature (1994) 1.93

Effect of the prophage and penicillinase plasmid of the recipient strain upon the transduction and the stability of methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 1.92

Epidermal growth factor. Location of disulfide bonds. J Biol Chem (1973) 1.90

Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. J Biol Chem (1982) 1.89

Leukotactic factors elaborated by virus-infected tissues. J Exp Med (1972) 1.89

Antigenic variation and protective immunity in Plasmodium knowlesi malaria. Immunology (1972) 1.89

Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89

Co-localization of 125I-epidermal growth factor and ferritin-low density lipoprotein in coated pits: a quantitative electron microscopic study in normal and mutant human fibroblasts. J Cell Biol (1982) 1.88

Interaction of epidermal growth factor (EGF) with cultured fibroblasts. Adv Metab Disord (1975) 1.88

Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology (1974) 1.87

Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluorescence and membrane enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.86

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84

Women's recall of obstetric complications in south Kalimantan, Indonesia. Stud Fam Plann (1997) 1.82

Drug utilization in a newborn intensive care unit. J Pediatr (1976) 1.82

The EH and SH3 domain Ese proteins regulate endocytosis by linking to dynamin and Eps15. EMBO J (1999) 1.82

Mutations in prophage phi11 that impair the transducibility of their Staphylococcus aureus lysogens for methicillin resistance. J Bacteriol (1977) 1.78